Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran

被引:6
|
作者
Toofan, Firooz [1 ]
Hosseini, Seyed Mojtaba [1 ]
Alimohammadzadeh, Khalil [1 ,2 ]
Jafari, Mehrnoosh [1 ]
Bahadori, Mohammadkarim [3 ]
机构
[1] Islamic Azad Univ, Dept Hlth Serv Management, North Tehran Branch, Tehran, Iran
[2] Islamic Azad Univ, Tehran Med Sci Branch, Hlth Econ Policy Res Ctr, Tehran, Iran
[3] Baqiyatallah Univ Med Sci, Hlth Management Res Ctr, Tehran, Iran
关键词
Comorbidity; Iran; mortality; multimorbidity; SARS-CoV-2; MULTIMORBIDITY; OUTCOMES; CITY;
D O I
10.4103/jehp.jehp_1589_20
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
BACKGROUND: COVID-19 pandemic has spread all over the world. However, information regarding clinical characteristics and prognostic factors is scarce. The aim of this study was to explore the impact of preexistent chronic comorbid conditions and multimorbidity on risk of mortality in patients with COVID-19.MATERIALS AND METHODS: We designed a retrospective, cross-sectional, observational, single-center study. Data were analyzed from all consecutive patients diagnosed with COVID-19 who admitted in a pandemic hospital affiliated with Tabriz University of Medical Sciences, Tabriz, Iran, from February 20, 2020, to September 25, 2020. The independent effects of preexistent conditions were evaluated using multivariate logistic regression model.RESULTS: A total of 2597 hospitalized patients with COVID-19 were included. At least one preexistent condition was observed in 36.5% of study population. Multivariate logistic regression analysis showed that older age, male sex, diabetes, cardiovascular disease, hypertension, cancer, chronic kidney diseases, liver diseases, and chronic obstructive pulmonary disease were associated with increased risk of mortality. In addition, the number of comorbidities was significantly associated with increased odds of mortality compared to no-comorbidity.CONCLUSION: The results of this study suggest that patients with comorbidities have an increased risk of in-hospital mortality following COVID-19 infection.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] COVID-19 Mortality and Related Comorbidities in Hospitalized Patients in Bulgaria
    Dimova, Rositsa
    Stoyanova, Rumyana
    Blagoeva, Vesela
    Mavrov, Momchil
    Doykov, Mladen
    HEALTHCARE, 2022, 10 (08)
  • [2] Comorbidities associated with mortality or devere disease in hospitalized patients with COVID-19
    Carmen Gayol-Fernandez, M.
    Carmen Beceiro-Abad, M.
    Pazo-Nunez, Maria
    Mateo-Mosquera, Lara M.
    Paez-Guillan, Emilio
    Freire-Romero, M. Aurora
    Taboada-Muniz, Manuel
    Molinos-Castro, Sonia
    GALICIA CLINICA, 2022, 83 (03): : 18 - 27
  • [3] High postdischarge mortality in hospitalized COVID-19 patients with cardiovascular comorbidities
    Gasior, Mariusz
    Jaroszewicz, Jerzy
    Wita, Krystian
    Ciesla, Daniel
    Hudzik, Bartosz
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (7-8): : 749 - 751
  • [4] Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany
    Maximilian Seidel
    Bodo Hölzer
    Heiner Appel
    Nina Babel
    Timm H. Westhoff
    Journal of Nephrology, 2020, 33 : 871 - 874
  • [5] Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany
    Seidel, Maximilian
    Hoelzer, Bodo
    Appel, Heiner
    Babel, Nina
    Westhoff, Timm H.
    JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 871 - 874
  • [6] Comorbidities and mortality in COVID-19 patients
    Djaharuddin, Irawaty
    Munawwarah, Sitti
    Nurulita, Asvin
    Ilyas, Muh
    Tabri, Nur Ahmad
    Lihawa, Nurjannah
    GACETA SANITARIA, 2021, 35 : S530 - S532
  • [7] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Alqahtani, Saad M. A.
    Al Saglan, Naif S.
    AlShehry, Ali A.
    Hawan, Ali
    Dafalla, Badraltamam A. A.
    Mohamed, Nahid A. S.
    Kadasah, Ali S.
    Qureshi, Muhammad A.
    Al-Shahrani, Nourah A.
    Alfaifi, Abdulaziz S. Y.
    Alqahtani, Mohammed A.
    Alshafa, Fawwaz A.
    Alsalem, Ali A.
    Al-Imamah, Yahya A.
    Abdullah, Alahmari
    Alzulfah, Saad A. S.
    Mahmoud, Ibrahim M. A.
    Abuelhassan, Usama E.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2023, 17 (01)
  • [8] Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
    Lacedonia, Donato
    Scioscia, Giulia
    Santomasi, Carla
    Fuso, Paolo
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Mastroianni, Franco
    Larizza, Giovanni
    Sabato, Eugenio
    Profilo, Emanuela
    Resta, Emanuela
    Foschino Barbaro, Maria Pia
    Resta, Onofrio
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Saad M. A. alqahtani
    Naif S. Al Saglan
    Ali A. AlShehry
    Ali Hawan
    Badraltamam A. A.Dafalla
    Nahid A. S. Mohamed
    Ali S. Kadasah
    Muhammad A.Qureshi
    Nourah A. Al-Shahrani
    Abdulaziz S. Y. Alfaifi
    Mohammed A. Alqahtani
    Fawwaz A. Alshafa
    Ali A. Alsalem
    Yahya A. Al-Imamah
    Alahmari Abdullah
    Saad A. S. Alzulfah
    Ibrahim M. A. Mahmoud
    Usama E. Abuelhassan
    The Egyptian Journal of Bronchology, 17
  • [10] Impact of comorbidities and inflammatory markers on mortality of COVID-19 patients
    Karim, Azmat
    Shameem, Mohammad
    Talwar, Anjana
    Talwar, Deepak
    LUNG INDIA, 2024, 41 (01) : 40 - 46